Molecular Microencapsulation: Paclitaxel Formations in Aqueous Medium Using Hydrophobized Poly(L-Lysine Citramide Imide)

Abstract

Hydrophobized polyelectrolytes are able to aggregate in aqueous media and to form lipophilic microdomains which are much more stable than micelles made of amphiphilic diblock copolymers. Solubilization of paclitaxel in water by molecular encapsulation was attempted in the hydrophobic pockets present in the aggregates of hydrophobized poly(l-lysine citramide imide) polymers, PLCAi_xR_y, where x = percentage in imide groups and y = percentage in alkyl substituents per lysine citramide repeat unit. A comparison was made of the physical entrapment and the solubilization of paclitaxel in PLCAi₂₇C12₃₄, PLCAC12₇₅, PLCAi₁₃C7₃₀, PLCAC12₁₀₀ aggregates and in the usual allergic Cremophor® present in the Taxol® commercial formulation. PLCAi_xR_y polymers solubilized paclitaxel in the selected aqueous medium proportionally to the polymer concentration. For comparable amounts in weight, the polymers were two to six times less efficient than Cremophor® in terms of equivalent mass of solubilizing species. A comparison between PLCAi₁₃C7₃₀ and PLCAi_xC12_y polymers suggested that dodecyl hydrophobizing groups were more efficient than heptyl ones in promoting the physical entrapment of paclitaxel. The antitumoral activity of the polymer-solubilized paclitaxel was tested in vitro against an ovarian carcinoma cell line (A2780). The C12 systems showed cytotoxicity, the IC₅₀ values were statistically comparable in the 6.5-10.5 μg/L range. However, the amounts of drug incorporated in the polymer aggregates at the tested concentrations were still too low for clinical use. Improvements are expected from PLCA polymers with longer alkyl chains, greater hydrophobicity and higher concentrations.

Get full access to this article

View all access options for this article.

References

1. Crescenzi V. , Adv. Polym. Sci., 5, 358, (1968).

2. Dubin P.L. , and Straus U.P. , J. Phys. Chem., 64, 902 (1970).

3. Villiers C. , and Braud C. , Nouv. J. Chim., 2, 33, (1978).

4. Vert M. , Proceedings of the 28th IUPAC Macromolecular Symposium Macro 82 Amherst, Amherst Mass., USA, 1982, p. 377.

5. Braud C. , Vert M. , in "Polymers as Biomaterials," S.W. Shalaby , A. Hoffman , B.D. Ratner and T.A. Horbet Eds., Plenum Publ. Co., 1984, p. 17.

6. Vert M. , in "Polyvalent Polymeric Drug Carriers," CRC Crit. Rev. Ther., Drug Carrier Syst., 2, 91, (1986).

7. Yokoyama M. , Kwon G.S. , Ikano T. , Sakurai Y. , Seto T. and Kataoka K. , Bioconjug. Chem., 3, 295, (1992).

8. Huguet J. , Vert M. , J. Control. Rel., 1, 217, (1985).

9. Braud C. , Vert M. , Trends in Polymer Science, 3, 57, (1993).

10.

10. Gautier S. , Boustta M. , Vert M. , J. Bioact. Comp. Pol., 12, 77, (1997).

11.

11. Vert M. in "Polymers in Controlled Drug Delivery," L. Illum and S.S. Davis Eds., Wright, Bristol, 1987, p. 117.

12.

12. Illum L. , Huguet J. , Vert M. , Davis S.S. , J. Control. Rel., 3, 77, (1986).

13.

13. Abdellaoui K. , Boustta M. , Mordjani H. , Manfait M. , Vert M. , Europ. J. Pharm. Sci., 6, 61, (1998).

14.

14. Abdellaoui K. , Boustta M. , Mordjani H. , Manfait M. , Vert M. , in "Advanced Biomaterials in Biomedical Engineering and Drug Delivery Systems," N. Ogata , S.W. Kim , J. Feijen , and T. Okano Eds., Springer, Tokyo, (1996), p.57.

15.

15. Schiff P.B. , Fant J. , and Horwitz S.B. , Nature, 277, 665, (1979).

16.

16. Schiff, P.B. , and Horwitz S.B. , Proc. Natl. Acad. Sci. USA, 77, 1561, (1980).

17.

17. Rowinsky E.K. , Cazenave L.A. , Donehower R.C. , J. Natl. Cancer Inst., 82, 1247, (1990).

18.

18. Lorenz W. , Riemann H.J. , Schmal A. , Agents Action, 7, 63, (1977).

19.

19. Rowinsky E.K. , Onetto N. , Canetta R.M. , Arbuck S.G. , Semin. Oncol., 6, 646, (1992).

20.

20. Weiss, R.B. , Donehower P.H. , Wiernik P.H. , Ohnuma T. , Gralla R.J. , Trump D.L. , Baker J.R. , Van Echo D.A. , Von Hoff D.D. , Leyland-Jones B. , J. Clin. Oncol., 8, 1263, (1990).

21.

21. Waugh W.N. , Trissel L.A. , Stella V.J. , Am. J. Hosp. Pharm., 48, 1520, (1991).

22.

22. Rowinsky E.K. , McGuire W.P. , Guarnieri T. , Fisherman J.S. , Christian M.C. , Donehower R.C. , J. Clin. Oncol., 9, 1704, (1991).

23.

23. Runowicz C.D. , Wiernik P.H. , Einzig A.I. , Goldberg G.L. , Horwitz S.B. , Cancer, 71, 1591, (1993).

24.

24. Deutsh H. , Glinski J. , Hernandez M. , Haugwitz R. , Narayanan V. , Suffness M. , Zalkow L. , J. Med. Chem., 32, 788, (1989).

25.

24. Vyas D.M. , Wong H. , Crosswell A.R. , Casazza, A.M. , Knipe J.O. , Mamber S.W. , Doyle T.W. , Bioorg. Med. Chem. Lett., 1357, (1993).

26.

25. Ueda Y. , Mikkilineni A.B. , Knipe J.O. , Rose W.C. , Casazza A.M. , Vyas D.M. , Bioorg. Med. Chem. Lett., 3, 1761, (1993).

27.

27. Bissery M. , Guenard D. , Gueritte-Voegelein F. , Lavelle F. , Cancer Res., 51, 4845, (1991).

28.

28. Suffness M. , Annu. Rep. Med. Chem., 28, 305, (1993).

29.

29. Adams J.D. , Flora K.P. , Goldspiel B.R. , Wilson J.W. , Arbuck S.G. , Finley R. , J. Natl. Cancer Inst. Monogr., 15, 141, (1993).

30.

30. Rose W.C. , Anticancer Drugs, 3, 311, (1992).

31.

31. Tarr B.D., Sambandan T.G., Yalkowsky S.H., 4, 162, (1987).

32.

32. Alkan-Onyuksel H. , Ramakrishnan S. , Chai H.B. , Pezzuto J. , Pharm. Res., 11, 206, (1994).

33.

33. Sharma U.S. , Balasubramanian S.V. , Straubinger R.M. , J. Pharm. Sciences, 84, 1223, (1995).

34.

34. Greenwald R.B. , Gilbert C.W. , Pendri A. , Conover C.D. , Xia J. , Martinez A. , J. Med. Chem., 39, 424, (1996).

35.

35. Pesenti E. , Fanzetti C. , Biasoli G. , Ciomei M. , Pastori W. , Marsiglio A. , Proc. Am. Assoc. Cancer Res., 36, 307, (1995).

36.

36. Rafaeloff R. , Husain S.R. , Rahman A. , Proc. Ann. Meet. Am. Assoc. Cancer Res., 33:A2883, (1992).

37.

37. Riondel J. , Jacrot M. , Fessi H. , Puisieux F. , Poiter P. , In Vivo, 6, 23, (1992).

38.

38. Bartolli M.H. , Boitard M. , Fessi H. , Beriel H. , Devissguet J.H. , Picot F. , Puisieux F. , J. Microencapsulation, 7, 191, (1990).

39.

39. Straubinger R.M. , Sharma A. , Murray M. , Mayhew E. , J. Natl. Cancer Inst. Monogr., 15, 69, (1993).

40.

40. Glantz M.J. , Choy H. , Kearns C.M. , Mills P.C. , Wahlberg L.U. , Zuhowski E.G. , Calabresi P. , Egorin M.J. , J. Natl. Cancer Inst., 87, 1077, (1995).

41.

41. Alley M.C. , Scudiero D.A. , Monks A. , Cancer Res., 48, 589, (1988).

42.

42. Colangelo D. , Guo H.Y. , Connors K.M. , Kubota T. , Sivestro L. , Hoffmann R.M. , Anticancer Res., 12, 1373, (1992).

43.

43. Heo D.S. , Park J.G. , Hata K. , Day R. , Heberman R.B. , Whiteside T.L. , Cancer Res., 30, 3681, (1990).

44.

44. Bodmaier R. and Chen H. , J. Control. Rel., 12, 223, (1990).